Home
ARK Investment Management reported a 11.85% stake in Crispr Therapeutics CRSP · 10,165,400 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 11.85%
- Last report
- 10.51% · filed 25/02/14
- Shares held
- 10,165,400 sh
- Class
- Common Stock
- Event date
- 25/03/31
- Filed
- 25/05/14
11.85% stake · +1.3pp from the last report
- Stake
- 11.85%
- Last report
- 10.51%
- Since last report
- +1.3pp
Crispr Therapeutics trades, last 26 weeks
What else happened in Crispr Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30ARK Investment Management's other 5% stake reports
- ARK Investment Management
5% stakeTwist Bioscience
5% stakeTwist Bioscience
TWST
5.11% stake
3,385,850 sh
5.11% stake
Filed 09/08
- ARK Investment Management
5% stake10x Genomics
5% stake10x Genomics
TXG
8.56% stake
10,003,058 sh
8.56% stake
Filed 08/14
- ARK Investment Management
5% stakeTwist Bioscience
5% stakeTwist Bioscience
TWST
7.31% stake
4,549,803 sh
7.31% stake
Filed 08/14
- ARK Investment Management
5% stakeBeam Therapeutics
5% stakeBeam Therapeutics
BEAM
9.95% stake
10,234,862 sh
9.95% stake
Filed 08/14
- ARK Investment Management
5% stakePacific Biosciences of California
5% stakePacific Biosciences of California
PACB
9.59% stake
29,781,416 sh
9.59% stake
Filed 08/14
